{"id":1068078,"date":"2020-11-05T09:55:59","date_gmt":"2020-11-05T14:55:59","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/replimune-reports-fiscal-second-quarter-financial-results-and-provides-corporate-update\/"},"modified":"2024-08-18T11:42:38","modified_gmt":"2024-08-18T15:42:38","slug":"replimune-reports-fiscal-second-quarter-financial-results-and-provides-corporate-update","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/replimune-reports-fiscal-second-quarter-financial-results-and-provides-corporate-update.php","title":{"rendered":"Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update"},"content":{"rendered":"<p><![CDATA[RP1: Updated deep and durable response data with Opdivo\u00ae in CSCC and anti-PD1 failed melanoma continue to support ongoing registration-directed development]]><\/p>\n<p>See the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/05\/2121008\/0\/en\/Replimune-Reports-Fiscal-Second-Quarter-Financial-Results-and-Provides-Corporate-Update.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update\">Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post: Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/replimune-reports-fiscal-second-quarter-financial-results-and-provides-corporate-update.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068078","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068078"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068078"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068078\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}